Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C50H69N15O9 |
Molecular Weight | 1024.178 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CN=CN5)NC1=O)C(N)=O
InChI
InChIKey=JDKLPDJLXHXHNV-MFVUMRCOSA-N
InChI=1S/C50H69N15O9/c1-3-4-16-36(59-29(2)66)44(69)65-41-25-42(67)55-20-11-10-18-35(43(51)68)60-47(72)39(23-31-26-57-34-17-9-8-15-33(31)34)63-45(70)37(19-12-21-56-50(52)53)61-46(71)38(22-30-13-6-5-7-14-30)62-48(73)40(64-49(41)74)24-32-27-54-28-58-32/h5-9,13-15,17,26-28,35-41,57H,3-4,10-12,16,18-25H2,1-2H3,(H2,51,68)(H,54,58)(H,55,67)(H,59,66)(H,60,72)(H,61,71)(H,62,73)(H,63,70)(H,64,74)(H,65,69)(H4,52,53,56)/t35-,36-,37-,38+,39-,40-,41-/m0/s1
Molecular Formula | C50H69N15O9 |
Molecular Weight | 1024.178 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 7 / 7 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:57:20 GMT 2023
by
admin
on
Sat Dec 16 16:57:20 GMT 2023
|
Record UNII |
UPF5CJ93X7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Melanotan II
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
UPF5CJ93X7
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
121062-08-6
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
1323
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
Melanotan_II
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
DTXSID90153135
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
92432
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY | |||
|
100000134768
Created by
admin on Sat Dec 16 16:57:21 GMT 2023 , Edited by admin on Sat Dec 16 16:57:21 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Sexual effects are thought to be related to its ability to activate the MC4 receptor (though the MC3 is thought to also possibly be involved).
Ki
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
Melanotan II produces melanogenesis by activation of the MC1 receptor.
Ki
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
Binding Assay
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|